Fentanyl Citrate Injection shortage
Current 19 presentations ยท 3 manufacturers ยท first FDA posting 2012-01-01 ยท last update 2026-10-15
Manufacturers: Fresenius Kabi USA, LLC, Hikma Pharmaceuticals USA, Inc., Hospira, Inc., a Pfizer Company
Stated reasons (per FDA): Demand increase for the drug; Other
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-01) | Fresenius Kabi USA, LLC | Current Available |
โ | Check wholesalers for inventory | Posted 01/01/2012 Updated 10/15/2026 |
| Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-02) | Fresenius Kabi USA, LLC | Current Available |
โ | Check wholesalers for inventory | Posted 01/01/2012 Updated 10/15/2026 |
| Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-05) | Fresenius Kabi USA, LLC | Current Available |
โ | Check wholesalers for inventory | Posted 01/01/2012 Updated 10/15/2026 |
| Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-20) | Fresenius Kabi USA, LLC | Current Available |
โ | Check wholesalers for inventory | Posted 01/01/2012 Updated 10/15/2026 |
| Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-50) | Fresenius Kabi USA, LLC | Current Available |
โ | Check wholesalers for inventory | Posted 01/01/2012 Updated 10/15/2026 |
| Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 63323-808-11) | Fresenius Kabi USA, LLC | Current Available |
โ | Check wholesalers for inventory | Posted 01/01/2012 Updated 10/15/2026 |
| Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 0641-6024-10) | Hikma Pharmaceuticals USA, Inc. | Current Unavailable |
Other | Inventory available in vial presentations. | Posted 12/20/2023 Updated 10/14/2026 |
| Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 0641-6025-10) | Hikma Pharmaceuticals USA, Inc. | Current Unavailable |
Other | Inventory available in vial presentations. | Posted 12/20/2023 Updated 10/14/2026 |
| Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 0641-6026-05) | Hikma Pharmaceuticals USA, Inc. | Current Unavailable |
Other | Inventory available in vial presentations. | Posted 12/20/2023 Updated 10/14/2026 |
| Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6027-25) | Hikma Pharmaceuticals USA, Inc. | Current Available |
โ | Additional lots will be scheduled for manufacturing to meet demand. Product will be made available as it is released. | Posted 12/20/2023 Updated 10/14/2026 |
| Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6028-25) | Hikma Pharmaceuticals USA, Inc. | Current Available |
โ | Additional lots will be scheduled for manufacturing to meet demand. Product will be made available as it is released. | Posted 12/20/2023 Updated 10/14/2026 |
| Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6029-25) | Hikma Pharmaceuticals USA, Inc. | Current Available |
โ | Additional lots will be scheduled for manufacturing to meet demand. Product will be made available as it is released. | Posted 12/20/2023 Updated 10/14/2026 |
| Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6030-01) | Hikma Pharmaceuticals USA, Inc. | Current Available |
โ | Additional lots will be scheduled for manufacturing to meet demand. Product will be made available as it is released. | Posted 12/20/2023 Updated 10/14/2026 |
| Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6247-25) | Hikma Pharmaceuticals USA, Inc. | Current Available |
โ | Additional lots will be scheduled for manufacturing to meet demand. Product will be made available as it is released. | Posted 12/20/2023 Updated 10/14/2026 |
| Fentanyl Citrate, Injection, 100 mcg/2 mL (50 ug/1 mL) (NDC 0409-9094-22) | Hospira, Inc., a Pfizer Company | Current Available |
โ | Posted 01/01/2012 Updated 10/08/2026 | |
| Fentanyl Citrate, Injection, 250 mcg/5 mL (50 ug/1 mL) (NDC 0409-9094-25) | Hospira, Inc., a Pfizer Company | Current Limited Availability |
Demand increase for the drug | Limited Supply Available. Next Delivery: October 2026; Estimated Recovery: December 2026 | Posted 01/01/2012 Updated 10/08/2026 |
| Fentanyl Citrate, Injection, 500 mcg/10 mL (50 ug/1 mL) (NDC 0409-9094-28) | Hospira, Inc., a Pfizer Company | Current Limited Availability |
Demand increase for the drug | Limited Supply Available. Next Delivery: October 2026; Estimated Recovery: December 2026 | Posted 01/01/2012 Updated 10/08/2026 |
| Fentanyl Citrate, Injection, 1000 mcg/20 mL (50 ug/1 mL) (NDC 0409-9094-31) | Hospira, Inc., a Pfizer Company | Current Limited Availability |
Demand increase for the drug | Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: December 2026 | Posted 01/01/2012 Updated 10/08/2026 |
| Fentanyl Citrate, Injection, 2500 mcg/50 mL (50 ug/1 mL) (NDC 0409-9094-61) | Hospira, Inc., a Pfizer Company | Current Available |
โ | Posted 01/01/2012 Updated 10/08/2026 |
Source: FDA Drug Shortages Database ยท raw openFDA records
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)